We’re excited to let you know about another big “win” for Biotts: The Lower Silesia Voucher for Innovation will allow for the further development of our technology.
– We will use the grant to analyze the molecular structure of our transdermal carrier. The subject of the study carried out by the University of Opole will be the specialized analysis of substances that make up a patented carrier used to create a transdermal drug based on natural hydrophilic substances utilized in, among others, in the treatment of diabetic foot, ulcers and skin cancer. No drug of this type exists to date – not on the domestic market, and not anywhere else in the world – explains Dr. Jan Meler, Co-Founder of Biotts and Technologist behind unique formula used to create the drug.
For more on latest breakthrough projects, check out MamStartup: https://mamstartup.pl/biotts-otrzymal-wsparcie-134-tys-zl-w-ramach-dolnoslaskiego-bonu-na-innowacje/